Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Psychedelics.

Gregor Hasler: Three Guiding Questions — How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?

View Full Paper
Ask AI
Bookmark
Share

Authors

GHGregor Hasler

Discussion

Loading...

Member takes

Overview

Observational analysis reveals psychedelics enhance neuroplasticity in treating depression and PTSD, suggesting potential for mainstream integration.

Key Points

  • Psychedelics reshape brain function, leading to lasting clinical improvements in mood disorders.
  • Rapid antidepressant effects were observed in patients with depression and PTSD, pointing to the potential of innovative treatments.
  • Research uncovers mGluR5 as a biomarker, highlighting novel pathways for treating addiction and nicotine dependence.
  • Findings challenge traditional psychiatry, bridging rigorous neuroscience with compassionate practice to transform mental health care.

Cite This Study

Gregor Hasler (2025) studied this question.

synapsesocial.com/papers/68bb5f3e6d6d5674bcd033f7https://doi.org/10.61373/pp025k.0032
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A clinical research perspective on the regulation of medical and non‐medical use of psychedelic drugs2024 · 1 citations
  2. 2Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview2024 · 12 citations
  3. 3The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry2025 · 1 citations
  4. 4Psychedelic Renaissance: Evidence and Culture2024 · 1 citations
  5. 5Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes2025 · 2 citations